Skip to main content
Erschienen in: Archives of Virology 6/2010

01.06.2010 | Original Article

Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface

verfasst von: Jing Yang, Feng Wang, Linlin Tian, Jing Su, Xiangqian Zhu, Li Lin, Xiaoran Ding, Xuejun Wang, Shengqi Wang

Erschienen in: Archives of Virology | Ausgabe 6/2010

Einloggen, um Zugang zu erhalten

Abstract

Both fibronectin and the asialoglycoprotein receptor (ASGPR) have been identified by some investigators as partners for hepatitis B virus (HBV) envelope proteins. Because fibronectin is a natural ligand for ASGPR, we speculated that HBV might attach to ASGPR expressed on the hepatocyte surface via fibronectin. To test this hypothesis, we first confirmed by co-immunoprecipitation that ASGPR, fibronectin and HBsAg bind to each other in HepG2.2.15 cells, and possible binding domains were identified by GST pull-down. In addition, by measuring binding of HBsAg to cells, we found that ASGPR and fibronectin enhanced the binding capability of HBsAg to HepG2 cells, and even to 293T and CHO cells, which normally do not bind HBV. In conclusion, our findings suggest that both fibronectin and ASGPR mediate HBsAg binding to the cell surface, which provides further evidence for the potential roles of these two proteins in mediating HBV binding to liver cells.
Literatur
1.
Zurück zum Zitat Gripon P, Cannie I, Urban S (2005) Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol 79(3):1613–1622CrossRefPubMed Gripon P, Cannie I, Urban S (2005) Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein. J Virol 79(3):1613–1622CrossRefPubMed
2.
Zurück zum Zitat Glebe D, Urban S (2007) Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22–38PubMed Glebe D, Urban S (2007) Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol 13(1):22–38PubMed
3.
Zurück zum Zitat Petit MA, Capel F, Dubanchet S, Mabit H (1992) PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology 187:211–222CrossRefPubMed Petit MA, Capel F, Dubanchet S, Mabit H (1992) PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology 187:211–222CrossRefPubMed
4.
Zurück zum Zitat Duclos-Vallee JC, Capel F, Mabit H, Petit MA (1998) Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity. J Gen Virol 79:1665–1670PubMed Duclos-Vallee JC, Capel F, Mabit H, Petit MA (1998) Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity. J Gen Virol 79:1665–1670PubMed
5.
Zurück zum Zitat Neurath AR, Strick N, Sproul P (1992) Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope proteins. J Exp Med 175:461–469CrossRefPubMed Neurath AR, Strick N, Sproul P (1992) Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope proteins. J Exp Med 175:461–469CrossRefPubMed
6.
Zurück zum Zitat Neurath AR, Strick N, Li YY (1992) Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelop protein. J Exp Med 176:1561–1569CrossRefPubMed Neurath AR, Strick N, Li YY (1992) Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelop protein. J Exp Med 176:1561–1569CrossRefPubMed
7.
Zurück zum Zitat Gong ZJ, De Meyer S, Van Pelt J, Hertogs K, Depla E, De Bruin WC, Meheus L, Soumillion A, Fevery J, Yap SH (1999) Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection. Hepatology 29:576–584CrossRefPubMed Gong ZJ, De Meyer S, Van Pelt J, Hertogs K, Depla E, De Bruin WC, Meheus L, Soumillion A, Fevery J, Yap SH (1999) Transfection of a rat hepatoma cell line with a construct expressing human liver annexin V confers susceptibility to hepatitis B virus infection. Hepatology 29:576–584CrossRefPubMed
8.
Zurück zum Zitat Mehdi H, Kaplan MJ, Anlar FY, Yang X, Bayer R, Sutherland K, Peeples ME (1994) Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 68:2415–2424PubMed Mehdi H, Kaplan MJ, Anlar FY, Yang X, Bayer R, Sutherland K, Peeples ME (1994) Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 68:2415–2424PubMed
9.
Zurück zum Zitat Mehdi H, Yang X, Peeples ME (1996) An altered form of apolipoprotein H binds hepatitis B virus surface antigen most efficiently. Virology 217:58–66CrossRefPubMed Mehdi H, Yang X, Peeples ME (1996) An altered form of apolipoprotein H binds hepatitis B virus surface antigen most efficiently. Virology 217:58–66CrossRefPubMed
10.
Zurück zum Zitat Yang J, Bo XC, Ding XR, Dai JM, Zhang ML, Wang XH, Wang SQ (2006) Antisense oligonucleotides targeted against asialoglucoprotein receptor 1 block human hepatitis B virus replication. J Viral Hepat 13(3):158–165CrossRefPubMed Yang J, Bo XC, Ding XR, Dai JM, Zhang ML, Wang XH, Wang SQ (2006) Antisense oligonucleotides targeted against asialoglucoprotein receptor 1 block human hepatitis B virus replication. J Viral Hepat 13(3):158–165CrossRefPubMed
11.
Zurück zum Zitat Yang J, Ding X, Zhang Y, Bo X, Zhang M, Wang S (2006) Fibronectin is essential for hepatitis B virus propagation in vitro: may be a potential cellular target? Biochem Biophys Res Commun 344(3):757–764CrossRefPubMed Yang J, Ding X, Zhang Y, Bo X, Zhang M, Wang S (2006) Fibronectin is essential for hepatitis B virus propagation in vitro: may be a potential cellular target? Biochem Biophys Res Commun 344(3):757–764CrossRefPubMed
12.
Zurück zum Zitat Takahashi M, Takahashi M, Hamano S et al (2005) In vitro attachment of bovine hatched blastocysts on fibronectin is mediated by integrin in a RGD dependent manner. J Reprod Dev 51(1):47–57CrossRefPubMed Takahashi M, Takahashi M, Hamano S et al (2005) In vitro attachment of bovine hatched blastocysts on fibronectin is mediated by integrin in a RGD dependent manner. J Reprod Dev 51(1):47–57CrossRefPubMed
13.
Zurück zum Zitat Beer C, Pedersen L (2007) Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections. J Virol 81(15):8247–8257CrossRefPubMed Beer C, Pedersen L (2007) Matrix fibronectin binds gammaretrovirus and assists in entry: new light on viral infections. J Virol 81(15):8247–8257CrossRefPubMed
14.
Zurück zum Zitat Takahashi M, Takahashi M, Hamano S et al (2005) In vitro attachment of bovine hatched blastocysts on fibronectin is mediated by integrin in a RGD dependent manner. J Reprod Dev 51(1):47–57CrossRefPubMed Takahashi M, Takahashi M, Hamano S et al (2005) In vitro attachment of bovine hatched blastocysts on fibronectin is mediated by integrin in a RGD dependent manner. J Reprod Dev 51(1):47–57CrossRefPubMed
15.
Zurück zum Zitat Schwarz-Linek U, Hook M, Potts JR (2004) The molecular basis of fibronectin-mediated bacterial adherence to host cells. Mol Microbiol 52(3):631–641CrossRefPubMed Schwarz-Linek U, Hook M, Potts JR (2004) The molecular basis of fibronectin-mediated bacterial adherence to host cells. Mol Microbiol 52(3):631–641CrossRefPubMed
16.
Zurück zum Zitat Bozzini S, Falcone V, Conaldi PG et al (1998) Heparin-binding domain of human fibronectin binds HIV-1 gp120/160 and reduces virus infectivity. J Med Virol 54:44–53CrossRefPubMed Bozzini S, Falcone V, Conaldi PG et al (1998) Heparin-binding domain of human fibronectin binds HIV-1 gp120/160 and reduces virus infectivity. J Med Virol 54:44–53CrossRefPubMed
17.
Zurück zum Zitat Julkunen I, Hautanen A, Keski-Oja J (1983) Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40:876–881PubMed Julkunen I, Hautanen A, Keski-Oja J (1983) Interaction of viral envelope glycoproteins with fibronectin. Infect Immun 40:876–881PubMed
18.
Zurück zum Zitat Keski-Oja J, Hautanen A, Julkunen J (1987) Fibronectin and viral pathogenesis. Rev Infect Dis 9:404–411 Keski-Oja J, Hautanen A, Julkunen J (1987) Fibronectin and viral pathogenesis. Rev Infect Dis 9:404–411
19.
Zurück zum Zitat Greco G, Pal S, Pasqualini R, Schnapp LM (2002) Matrix fibronectin increases HIV stability and infectivity. J Immunol 168(11):5722–5729PubMed Greco G, Pal S, Pasqualini R, Schnapp LM (2002) Matrix fibronectin increases HIV stability and infectivity. J Immunol 168(11):5722–5729PubMed
20.
Zurück zum Zitat Liu X, Collodi P (2002) Novel form of fibronectin from zebrafish mediates infectious hematopoietic necrosis virus infection. J Virol 76(2):492–498CrossRefPubMed Liu X, Collodi P (2002) Novel form of fibronectin from zebrafish mediates infectious hematopoietic necrosis virus infection. J Virol 76(2):492–498CrossRefPubMed
21.
Zurück zum Zitat Boshuizen JA, Rossen JW, Sitaram CK, Kimenai FF, Simons-Oosterhuis Y, Laffeber C, Büller HA, Einerhand AW (2004) Rotavirus enterotoxin NSP4 binds to the extracellular matrix proteins laminin-β3 and fibronectin. J Virol 78(18):10045–10053CrossRefPubMed Boshuizen JA, Rossen JW, Sitaram CK, Kimenai FF, Simons-Oosterhuis Y, Laffeber C, Büller HA, Einerhand AW (2004) Rotavirus enterotoxin NSP4 binds to the extracellular matrix proteins laminin-β3 and fibronectin. J Virol 78(18):10045–10053CrossRefPubMed
22.
23.
Zurück zum Zitat Budkowska A, Bedossa P, Groh F, Louise A, Pillot J (1995) Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain. J Virol 69(2):840–848PubMed Budkowska A, Bedossa P, Groh F, Louise A, Pillot J (1995) Fibronectin of human liver sinusoids binds hepatitis B virus: identification by an anti-idiotypic antibody bearing the internal image of the pre-S2 domain. J Virol 69(2):840–848PubMed
24.
Zurück zum Zitat Treichel U, Buschenfelde KHMZ, Stockert RJ et al (1994) The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol 75:3021–3029CrossRefPubMed Treichel U, Buschenfelde KHMZ, Stockert RJ et al (1994) The asialoglycoprotein receptor mediates hepatic binding and uptake of natural hepatitis B virus particles derived from viraemic carriers. J Gen Virol 75:3021–3029CrossRefPubMed
25.
Zurück zum Zitat Treichel U, Buschenfelde KHMZ, Gerken G et al (1997) Receptor-mediated entry of hepatitis B virus particles into liver cells. Arch Virol 142:493–498CrossRefPubMed Treichel U, Buschenfelde KHMZ, Gerken G et al (1997) Receptor-mediated entry of hepatitis B virus particles into liver cells. Arch Virol 142:493–498CrossRefPubMed
26.
Zurück zum Zitat Paietta E, Stockert RJ, Racevskis J (1992) Differences in the abundance of variably spliced transcripts for the second asialoglycoprotein receptor polypeptide, H2, in normal and transformed human liver. Hepatology 15(3):395–402CrossRefPubMed Paietta E, Stockert RJ, Racevskis J (1992) Differences in the abundance of variably spliced transcripts for the second asialoglycoprotein receptor polypeptide, H2, in normal and transformed human liver. Hepatology 15(3):395–402CrossRefPubMed
27.
Zurück zum Zitat Owada T, Matsubayashi K, Sakata H et al (2006) Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry. J Viral Hepat 13:11–18CrossRefPubMed Owada T, Matsubayashi K, Sakata H et al (2006) Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry. J Viral Hepat 13:11–18CrossRefPubMed
28.
Zurück zum Zitat Yang J, Bo XC, Yao J, Yang NM, Wang SQ (2005) Differentially expressed cellular genes following HBV: potential targets of anti-HBV drugs? J Viral Hepat 12:357–363CrossRefPubMed Yang J, Bo XC, Yao J, Yang NM, Wang SQ (2005) Differentially expressed cellular genes following HBV: potential targets of anti-HBV drugs? J Viral Hepat 12:357–363CrossRefPubMed
29.
Zurück zum Zitat Otsuka M, Aizaki H, Kato N et al (2003) Differential cellular gene expression induced by hepatitis B and C viruses. Biochem Biophys Res Commun 300(2):443–447CrossRefPubMed Otsuka M, Aizaki H, Kato N et al (2003) Differential cellular gene expression induced by hepatitis B and C viruses. Biochem Biophys Res Commun 300(2):443–447CrossRefPubMed
30.
Zurück zum Zitat Rotundo RF, Rebres RA, Mckeown-Longo PJ, Blumenstock FA, Saba TM (1998) Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver. Hepatology 28:475–485CrossRefPubMed Rotundo RF, Rebres RA, Mckeown-Longo PJ, Blumenstock FA, Saba TM (1998) Circulating cellular fibronectin may be a natural ligand for the hepatic asialoglycoprotein receptor: possible pathway for fibronectin deposition and turnover in the rat liver. Hepatology 28:475–485CrossRefPubMed
31.
Zurück zum Zitat Sells MA, Zelent AZ, Shvartsman M, Acs G (1988) Replication hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 62:2836–2844PubMed Sells MA, Zelent AZ, Shvartsman M, Acs G (1988) Replication hepatitis B virus in HepG2 cells that produce infectious virions. J Virol 62:2836–2844PubMed
32.
Zurück zum Zitat Sells MA, Chen ML, Acs G (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84:1005–1009CrossRefPubMed Sells MA, Chen ML, Acs G (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 84:1005–1009CrossRefPubMed
33.
Zurück zum Zitat Falco SD, Ruvoletto G, Verdoliva A, Ruvo M, Raucci A et al (2001) Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem 276(39):36613–36623CrossRefPubMed Falco SD, Ruvoletto G, Verdoliva A, Ruvo M, Raucci A et al (2001) Cloning and expression of a novel hepatitis B virus-binding protein from HepG2 cells. J Biol Chem 276(39):36613–36623CrossRefPubMed
Metadaten
Titel
Fibronectin and asialoglyprotein receptor mediate hepatitis B surface antigen binding to the cell surface
verfasst von
Jing Yang
Feng Wang
Linlin Tian
Jing Su
Xiangqian Zhu
Li Lin
Xiaoran Ding
Xuejun Wang
Shengqi Wang
Publikationsdatum
01.06.2010
Verlag
Springer Vienna
Erschienen in
Archives of Virology / Ausgabe 6/2010
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-010-0657-5

Weitere Artikel der Ausgabe 6/2010

Archives of Virology 6/2010 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.